68 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Article Searches
Stryker Corporation (SYK) Q4 2023 Earnings Call Transcript https://seekingalpha.com/article/4666216-stryker-corporation-syk-q4-2023-earnings-call-transcript?source=feed_sector_transcripts Jan 30, 2024 - Stryker Corporation (NYSE:NYSE:SYK) Q4 2023 Earnings Conference Call January 30, 2024 4:30 PM ETCompany ParticipantsKevin Lobo – Chair and Chief Executive...
Stryker (SYK) Reports Q4 Earnings: What Key Metrics Have to Say https://www.zacks.com/stock/news/2218369/stryker-syk-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2218369 Jan 30, 2024 - The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CVS Health (CVS) Q4 Earnings Top Estimates, 2024 EPS View Down https://www.zacks.com/stock/news/2222702/cvs-health-cvs-q4-earnings-top-estimates-2024-eps-view-down?cid=CS-ZC-FT-analyst_blog|earnings_article-2222702 Feb 07, 2024 - Robust sales growth across all three operating segments contributes to CVS Health's (CVS) Q4 revenues.
Here's Why You Should Retain IDEXX (IDXX) Stock for Now https://www.zacks.com/stock/news/2227054/here-s-why-you-should-retain-idexx-idxx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2227054 Feb 15, 2024 - Investors are optimistic about IDEXX (IDXX) growth in CAG business and strong global performance
Here's Why Investors Should Retain ResMed (RMD) Stock for Now https://www.zacks.com/stock/news/2228766/here-s-why-investors-should-retain-resmed-rmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2228766 Feb 20, 2024 - Investors are optimistic about ResMed's (RMD) increased adoption of AirSense10 and AirSense11 devices.
Illumina (ILMN) Rides on NGS Portfolio Expansion Amid Macro Woe https://www.zacks.com/stock/news/2228631/illumina-ilmn-rides-on-ngs-portfolio-expansion-amid-macro-woe?cid=CS-ZC-FT-analyst_blog|zer_report_update-2228631 Feb 20, 2024 - In reproductive health, Illumina (ILMN) primarily focuses on driving noninvasive prenatal testing (NIPT) adoption globally.
Medtronic (MDT) Q3 Earnings Beat Estimates, 2024 View Up https://www.zacks.com/stock/news/2228769/medtronic-mdt-q3-earnings-beat-estimates-2024-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2228769 Feb 20, 2024 - Medtronic's (MDT) third-quarter organic growth reflects broad strength across businesses and geographies.
Sight Sciences (SGHT) to Expand in Europe With New Launch https://www.zacks.com/stock/news/2229444/sight-sciences-sght-to-expand-in-europe-with-new-launch?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2229444 Feb 21, 2024 - By tapping into the European market, Sight Sciences (SGHT) aims to capitalize on the growing demand for advanced eye care technologies.
Here's Why Investors Should Retain STERIS (STE) Stock for Now https://www.zacks.com/stock/news/2232656/here-s-why-investors-should-retain-steris-ste-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2232656 Feb 27, 2024 - Investors are optimistic about STERIS (STE) on continuous recovery of healthcare procedures and upbeat 2024 guidance.
HAE or SYK: Which Is the Better Value Stock Right Now? https://www.zacks.com/stock/news/2232605/hae-or-syk-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2232605 Feb 27, 2024 - HAE vs. SYK: Which Stock Is the Better Value Option?

Pages: 1234567

Page 1>